Cutaneous adverse events associated with long-term immunomodulating therapy in multiple sclerosis

Benzer Materyaller

• Prevalence of cutaneous adverse events associated with long-term disease-modifying therapy and their impact on health-related quality of life in patients with multiple sclerosis: a cross-sectional study
  Yazar:: Balak, Deepak MW, ve diğerleri
  Baskı/Yayın Bilgisi: (2013)
• Treatment of lupus erythematosus with fumaric acid ester derivatives: two case-reports
  Yazar:: Balak, Deepak MW, ve diğerleri
  Baskı/Yayın Bilgisi: (2011)
• Cutaneous adverse events in multiple sclerosis patients treated with daclizumab
  Yazar:: Cortese, Irene, ve diğerleri
  Baskı/Yayın Bilgisi: (2016)
• Cutaneous Adverse Events Associated with Interferon-β Treatment of Multiple Sclerosis
  Yazar:: Kolb-Mäurer, Annette, ve diğerleri
  Baskı/Yayın Bilgisi: (2015)
• Long-Term Adverse Events of Rituximab in Multiple Sclerosis Patients, Isfahan, Iran
  Yazar:: Ali Rahimisadegh, ve diğerleri
  Baskı/Yayın Bilgisi: (2025-06-01)